MedTrace Logo

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

NCT01071681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1589

Last updated 2011-11-02

No results posted yet for this study

Summary

This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients

Conditions

  • Arterial Hypertension

Interventions

DRUG

Telmisartan (Kinzal/Pritor, BAY68-9291)

Patients under daily life treatment receiving Pritor according to local drug information.

Sponsors & Collaborators

  • International Clinical Trials Association

    collaborator OTHER

  • Bayer

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • France

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01071681 on ClinicalTrials.gov